Skip to main content

Advertisement

Log in

Chronic Low Dose Prostaglandin and Neonatal Heart Block

  • Case Report
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Long-term prostaglandin use is commonly associated with side effects such as cortical proliferation of the bones, hypertrophic pyloric stenosis, and soft tissue swelling of the extremities. We report a neonate with critical coarctation of the aorta, who developed second and third degree atrioventricular blocks associated with prolonged prostaglandin E1 (PGE1) infusion. Interestingly, these conduction blocks only occurred at low PGE1 dose. The rhythm disturbances resolved promptly with the discontinuation of PGE1 following surgical repair.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Beamish RE, Das PK, Karmazyn M, Dhalla NS (1985) Prostaglandins and heart disease. Can J Cardiol 1:66–74

    CAS  PubMed  Google Scholar 

  2. Bourke KD, Sondheimer HM, Ivy DD, Pietra B, Gleason BK, Mashburn C, Boucek MM (2003) Improved pretransplant management of infants with hypoplastic left heart syndrome enables discharge to home while waiting for transplantation. Pediatr Cardiol 24:538–543

    Article  CAS  PubMed  Google Scholar 

  3. Aykanat A, Yavuz T, Ozalkaya E, Topcuoglu S, Ovali F, Karatekin G (2016) Long-term prostaglandin E1 infusion for newborns with critical congenital heart disease. Pediatr Cardiol 37:131–134

    Article  PubMed  Google Scholar 

  4. Peled N, Dagan O, Babyn P, Silver MM, Barker G, Hellmann J, Scolnik D, Koren G (1992) Gastric-outlet obstruction induced by prostaglandin therapy in neonates. N Engl J Med 327:505–510

    Article  CAS  PubMed  Google Scholar 

  5. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dea460fa-d05e-4191-8461-f185a711ad89. Accessed 31 March 2017

  6. Alhussin W, Verklan MT (2016) Complications of long-term prostaglandin E1 use in newborns with ductal-dependent critical congenital heart disease. J Perinat Neonatal Nurs 30:73–79

    Article  PubMed  Google Scholar 

  7. Ustun N, Dilli D, Zenciroglu A, Okumus N, Cinar G, Ozgur S, Koc M (2013) Long-term prostaglandin E1 use in newborns with duct-dependent congenital heart diseases: one year experience of a tertiary neonatal intensive care unit in Turkey. Anadolu Kardiyol Derg 13:732–734

    PubMed  Google Scholar 

  8. Lewis AB, Freed MD, Heymann MA, Roehl SL, Kensey RC (1981) Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64:893–898

    Article  CAS  PubMed  Google Scholar 

  9. De Smit E, Theodorou M, Hildebrand GD, Bloom P (2011) Heart block following topical latanoprost treatment. BMJ Case Rep. doi:10.1136/bcr.08.2011.4607

    PubMed  PubMed Central  Google Scholar 

  10. Swift A, Karmazyn M, Horrobin DF, Manku MS, Karmali RA, Morgan RO, Ally AI (1978) Low prostaglandin concentrations cause cardiac rhythm disturbances. Effect reversed by low levels of copper or chloroquine. Prostaglandins 15:651–657

    Article  CAS  PubMed  Google Scholar 

  11. Karmazyn M, Dhalla NS (1980) A selective concentration-dependent dysrhythmogenic and antidysrhythmic action of prostaglandins E2, F2 alpha and I2 (prostacyclin) on isolated rat hearts. Experientia 36:996–998

    Article  CAS  PubMed  Google Scholar 

  12. Rao TS, Seth SD, Manchanda SC, Nayar U (1989) Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis. Arch Int Pharmacodyn Ther 302:128–144

    CAS  PubMed  Google Scholar 

  13. Anderson RH, Becker AE, Arnold R, Wilkinson JL (1974) The conducting tissues in congenitally corrected transposition. Circulation 50:911–923

    Article  CAS  PubMed  Google Scholar 

  14. Baruteau AE, Pass RH, Thambo JB, Behaghel A, Le Pennec S, Perdreau E, Combes N, Liberman L, McLeod CJ (2016) Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management. Eur J Pediatr 175:1235–1248

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Johansen AS, Herlin T (1998) Neonatal lupus syndrome. Association with complete congenital atrioventricular block. Ugeskr Laeger 160:2521–2525

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Safwat A. Aly.

Ethics declarations

Conflict of interest

All the authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aly, S.A., Awad, S.M., Abdulla, Ri. et al. Chronic Low Dose Prostaglandin and Neonatal Heart Block. Pediatr Cardiol 38, 1515–1518 (2017). https://doi.org/10.1007/s00246-017-1633-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-017-1633-6

Keywords

Navigation